Press ReleaseK-Beauty Leader Dr.Althea Hits 35 Million Global Sales for 345 Relief Cream, Unveils Expanded 345 Relief Line NEW YORK, Sept. 30, 2026 /PRNewswire/ — Dr.Althea, a leading Korean dermatology-inspired… CISION PRNewswireSeptember 30, 2026
Press ReleaseVoiskey Introduces Team Expression Solution to Advance Expression Efficiency in the Workplace SINGAPORE, Sept. 30, 2026 /PRNewswire/ — Voiskey, an innovative AI voice-typing application, today… CISION PRNewswireSeptember 30, 2026
Press ReleaseAs AI Investing Develops Faster in 2026, Why Do You Need to Know Where the "Brakes" Are? SINGAPORE, Sept. 30, 2026 /PRNewswire/ — On 26 September 2026, Singapore’s Minister… CISION PRNewswireSeptember 30, 2026
Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations CONSHOHOCKEN, Pa., Sept. 30, 2026 /PRNewswire/ — Suvoda, a global clinical trial… CISION PRNewswireSeptember 30, 2026
CoW Swap Opens TWAP Orders to Every EOA Wallet, Removing the Safe-Only Barrier The order type professional trading desks use to limit market impact is… CISION PRNewswireSeptember 30, 2026
Press ReleaseWaterdrop Filter Brings Better Water to Healthier Fall Routines This Prime Big Deal Days LOS ANGELES, Sept. 30, 2026 /PRNewswire/ — Waterdrop Filter, a global water… CISION PRNewswireSeptember 30, 2026
Press ReleasePiramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month Piramal and NP2 are set to complete the drug development phase of… CISION PRNewswireSeptember 30, 2026
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC First clinical program built on Phrontline’s DLP1 branched dual-payload linker platform HANGZHOU,… CISION PRNewswireSeptember 30, 2026
